Lorenzo Livi

11.4k total citations · 1 hit paper
391 papers, 6.0k citations indexed

About

Lorenzo Livi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lorenzo Livi has authored 391 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 187 papers in Pulmonary and Respiratory Medicine, 138 papers in Oncology and 107 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lorenzo Livi's work include Breast Cancer Treatment Studies (88 papers), Advanced Radiotherapy Techniques (81 papers) and Prostate Cancer Treatment and Research (55 papers). Lorenzo Livi is often cited by papers focused on Breast Cancer Treatment Studies (88 papers), Advanced Radiotherapy Techniques (81 papers) and Prostate Cancer Treatment and Research (55 papers). Lorenzo Livi collaborates with scholars based in Italy, United States and France. Lorenzo Livi's co-authors include Icro Meattini, Isacco Desideri, Pierluigi Bonomo, Gabriele Simontacchi, Daniela Greto, Fabiola Paiar, Beatrice Detti, Calogero Saieva, Monica Mangoni and L. Marrazzo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Lorenzo Livi

371 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial

2020 238 citations Icro Meattini, L. Marrazzo et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lorenzo Livi Italy	36	2.6k	1.7k	1.7k	1.5k	1.5k	391	6.0k
D. Azria France	46	2.8k 1.1×	1.7k 1.0×	3.4k 2.0×	1.2k 0.8×	2.0k 1.3×	372	7.6k
Jürgen Dunst Germany	45	3.0k 1.1×	1.6k 1.0×	1.8k 1.0×	863 0.6×	877 0.6×	234	6.9k
Icro Meattini Italy	29	1.6k 0.6×	1.6k 0.9×	1.4k 0.8×	983 0.7×	956 0.6×	238	4.0k
Christian Rübe Germany	38	3.4k 1.3×	741 0.4×	1.4k 0.8×	936 0.6×	2.3k 1.5×	150	7.0k
Giovanna Gagliardi Sweden	25	2.9k 1.1×	2.0k 1.2×	1.0k 0.6×	3.0k 2.0×	2.6k 1.7×	39	6.1k
Volker Rudat Germany	33	1.8k 0.7×	859 0.5×	1.3k 0.8×	905 0.6×	1.3k 0.9×	128	5.4k
Walter Van den Bogaert Belgium	41	2.4k 0.9×	2.1k 1.3×	1.8k 1.1×	1.9k 1.3×	1.9k 1.3×	78	6.8k
Matthew J. Schipper United States	39	2.7k 1.0×	631 0.4×	1.1k 0.7×	1.6k 1.1×	1.8k 1.2×	235	6.0k
Candace R. Correa United States	16	2.4k 0.9×	5.0k 2.9×	2.4k 1.4×	3.1k 2.0×	2.7k 1.8×	24	8.7k
Brenda Shank United States	23	2.2k 0.8×	940 0.6×	1.6k 0.9×	1.9k 1.2×	1.8k 1.2×	55	5.5k

Countries citing papers authored by Lorenzo Livi

Since Specialization

Citations

This map shows the geographic impact of Lorenzo Livi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenzo Livi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenzo Livi more than expected).

Fields of papers citing papers by Lorenzo Livi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorenzo Livi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenzo Livi. The network helps show where Lorenzo Livi may publish in the future.

Co-authorship network of co-authors of Lorenzo Livi

This figure shows the co-authorship network connecting the top 25 collaborators of Lorenzo Livi. A scholar is included among the top collaborators of Lorenzo Livi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorenzo Livi. Lorenzo Livi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Greto, Daniela, Luca Visani, Giuseppe Lombardi, et al.. (2025). Integrating nutritional status and hematological biomarkers for enhanced prognosis prediction in glioma patients: A systematic review. Clinical Nutrition ESPEN. 66. 269–280. 1 indexed citations

Francolini, Giulio, Vanessa Di Cataldo, Saverio Caini, et al.. (2025). PERSIAN trial: Early results from a randomized phase II trial testing apalutamide and stereotactic body radiation therapy for low-burden, metastatic, hormone-sensitive prostate cancer.. Journal of Clinical Oncology. 43(5_suppl). 160–160. 3 indexed citations

Dingemans, Anne‐Marie C., Konstantinos Syrigos, Lorenzo Livi, et al.. (2025). Intracranial activity of sotorasib vs docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer from a global, phase 3, randomized controlled trial. Lung Cancer. 207. 108683–108683.

Becherini, Carlotta, Viola Salvestrini, Isacco Desideri, et al.. (2024). Impact of fosaprepitant in the prevention of nausea and emesis in head and neck cancer patients undergoing cisplatin-based chemoradiation: a pilot prospective study and a review of literature. La radiologia medica. 129(3). 457–466. 1 indexed citations

Salvestrini, Viola, Carlotta Becherini, Isacco Desideri, et al.. (2023). Long Term Clinical Outcomes of a Cohort of Lung-Only Oligometastatic HNSCC Patients Treated with SBRT. International Journal of Radiation Oncology*Biology*Physics. 117(2). e601–e602. 1 indexed citations

Banini, Marco, Viola Salvestrini, Alessandra Vultaggio, et al.. (2023). Desensitization Protocol for Cemiplimab-Related Infusion Reaction in Cutaneous Squamous Cell Carcinoma: A Case Report and Literature Review. Current Oncology. 30(7). 6699–6707. 2 indexed citations

Loi, Mauro, Mariangela Sottili, Laura Calosi, et al.. (2022). Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer. Clinical & Translational Oncology. 24(7). 1395–1402. 4 indexed citations

Roviello, Giandomenico, Isacco Desideri, Marco Brugia, et al.. (2021). Endocrine-related adverse events in a large series of cancer patients treated with anti-PD1 therapy. Endocrine. 74(1). 172–179. 25 indexed citations

Francolini, Giulio, Antonio Bruni, Giovanna Mantini, et al.. (2020). Early results from a phase II randomized trial testing stereotactic body radiation therapy in patients with oligometastatic castration resistant prostate cancer undergoing I line treatment with abiraterone acetate (ARTO trial-NCT03449719). European Urology Open Science. 21. S150–S150. 3 indexed citations

10.

Desideri, Isacco, Giulio Francolini, Giulio Alberto Carta, et al.. (2019). Efficacy and Tolerability of CyberKnife Stereotactic Robotic Radiotherapy for Primary or Secondary Orbital Lesions: A Single-Center Retrospective Experience. Technology in Cancer Research & Treatment. 18. 1077086209–1077086209. 1 indexed citations

11.

Livi, Lorenzo, Vieri Scotti, Isacco Desideri, et al.. (2019). Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial. European Journal of Cancer. 108. 100–110. 13 indexed citations

12.

Francolini, Giulio, Beatrice Detti, Gianluca Ingrosso, et al.. (2018). Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature. Critical Reviews in Oncology/Hematology. 131. 24–29. 25 indexed citations

13.

Scoccianti, Silvia, Beatrice Detti, Davide Gadda, et al.. (2015). Organs at risk in the brain and their dose-constraints in adults and in children: A radiation oncologist’s guide for delineation in everyday practice. Radiotherapy and Oncology. 114(2). 230–238. 148 indexed citations

14.

Sottili, Mariangela, et al.. (2015). Biological basis of radiation-induced pulmonary fibrosis. 3(3). 325–331. 2 indexed citations

15.

Livi, Lorenzo, Pierluigi Bonomo, Icro Meattini, et al.. (2013). Paclitaxel and bevacizumab in first-line treatment for HER2-negative metastatic breast cancer: single-center experience. Medical Oncology. 30(1). 434–434. 6 indexed citations

16.

Bonomo, Pierluigi, Lorenzo Livi, Icro Meattini, et al.. (2013). Stereotactic body radiotherapy for cardiac and paracardiac metastases: University of Florence experience. La radiologia medica. 118(6). 1055–1065. 13 indexed citations

17.

Masi, Laura, et al.. (2013). Impact of plan parameters on the dosimetric accuracy of volumetric modulated arc therapy. Medical Physics. 40(7). 71718–71718. 220 indexed citations

18.

Scoccianti, Silvia, Benedetta Agresti, Gabriele Simontacchi, et al.. (2012). From a waiting list to a priority list: a computerized model for an easy-to-manage and automatically updated priority list in the booking of patients waiting for radiotherapy.. PubMed. 98(6). 728–35. 3 indexed citations

19.

Magrini, Stefano Maria, Sandro Tonoli, Loredana Costa, et al.. (2011). A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian Centres from 1977 to 2000. Part II: evolving technical choices and toxicity patterns. La radiologia medica. 117(4). 715–724. 1 indexed citations

20.

Livi, Lorenzo, Calogero Saieva, Simona Borghesi, et al.. (2009). Doxorubicin and Cyclophosphamide versus Cyclophosphamide, Methotrexate, and 5-Fluorouracil as Adjuvant Chemotherapy in Breast Cancer. Journal of Chemotherapy. 21(5). 558–565. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact